Analysts Set Maplight Therapeutics, Inc. (NASDAQ:MPLT) Target Price at $31.80

Shares of Maplight Therapeutics, Inc. (NASDAQ: MPLT - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, four have assigned a buy recommendation and one